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OBJECTIVES: Breast cancer is the most common malignant disease in Western
women. In the ONCOTYROL research center, a decision-analytic Breast Cancer
Outcomes & Policy (BCOP) model is being developed to evaluate the cost-effective-
ness of the new 21-gene assay that supports personalized decisions on adjuvant
chemotherapy. Model validation is essential to build confidence in the model re-
sults and to influence decision makers. Based on the new ISPOR-SMDM best prac-
tice recommendations, the process of model validation will be presented.
METHODS: The 21-gene assay was evaluated by simulating a hypothetical cohort
of 50year old women over a lifetime time horizon, adopting a societal perspective.
Main model outcomes were life-years gained, quality-adjusted life-years (QALYs)
gained and costs. Themajor focus of the presentation is on cross validation, i.e. the
comparison ofmodeling results between the discrete event simulation (DES) BCOP-
model and the Markov model of the THETA (Toronto Health Economics and Tech-
nology Assessment) Collaborative. Therefore, the BCOP-model has been populated
with the Canadian parameters of the THETA-model. RESULTS: Cross validation
started with comparison of model parameters related to the natural history of the
disease (undiscounted life years, number of breast cancer recurrences/deaths).
Thereafter, quality of life and cost outcomes were compared. The comparison
included point estimates of the outcomes of the deterministic analysis of the
Markovmodel aswell as the probabilistic runwith theDES results and combination
(ICERs). The absolute differences of expected life years gained for women after
surgery ranged from -0.35 to 0.43 years depending on the treatment strategy for
specific risk groups. For the probabilistic analysis, confidence intervals as well as
distributions of model outcomes were compared. CONCLUSIONS: Cross model
validation is a suitable approach to identify and correct modeling errors and to
explain remaining differences of modeling results.
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OBJECTIVES: Treatments for Alzheimer’s disease (AD) have currently been proved
for effectiveness but the selection needs to determine whether the clinical benefits
justify their additional costs. This study aimed to evaluate the cost-effectiveness of
donepezil treatment of mind to moderate AD compared with usual care in the
perspective of provider and society. METHODS: A Markov model composed of 4
health states (mild, moderate, severe, and death) was constructed to extrapolate
the results over a 5-year period. The study included costs of donepezil, costs of
comorbidity treatment, and costs of informal care. Effectiveness was measured in
terms of quality-adjusted life year (QALY). Cost and utility data were directly col-
lected from Thai AD population, but transition probabilities and the effect of done-
pezil were derived from literature review. All costs and effects were discounted at
3% per annum. One-way and probabilistic sensitivity analyses were performed.
RESULTS: The results demonstrated that with the threshold level of Thai 1GPD per
capita (approximately 148,000 Baht/QALY in 2011), donepezil was not a cost-effec-
tive treatment for mild or moderate AD for both societal (incremental cost-effec-
tiveness ratio (ICER)  284,473 Baht/QALY) and provider perspectives (ICER 
369,148 Baht/QALY). The resultswere very sensitive to utility value and the effect of
donepezil. Donepezil became more cost-effective than usual care when the will-
ingness to pay level increased to at least 155,000 and 375,000 Baht/QALY for societal
and provider perspectives respectively. CONCLUSIONS:With a limited health care
resources, using donepezil for the treatment of AD might not be cost-effective in
Thai context.
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OBJECTIVES: Chronic kidney disease (CKD) is a common and growing global health
issue characterized by reduced glomerular filtration rate (GFR, mLs/min/1.73m2).
While investigators have used short-term changes in GFR as an endpoint, the re-
lationship between this endpoint and long-term outcomes has not been reported.
The objective herewas to estimate andquantify this relationship in order to predict
the timing and number of cases of end-stage renal disease (ESRD) occurring over
the lifetime of a cohort of hypothetical CKD patients with moderate and advanced
disease.METHODS:We constructed a three-state Markov model (functioning kid-
ney, ESRD, and death) with an annual cycle length to project GFR on long-term
health outcomes. Using published GFR-specific risk equations, and adjusting for
confounders, we estimated the probability of ESRD (assumed at GFR10) and time
to death according to baseline GFR categories defined by the United States (U.S.)
Kidney Disease Outcomes Quality Initiative. Included in the modeling was a term
representing two types of CKD patients characterized by “slow” and “fast”
progression. RESULTS: For CKD patients aged 55 years, projected lifetime proba-
bilities of progressing to ESRD were: 0.05, 0.25, 0.81, and 0.97 in GFR categories
45-59, 30-44, 15-29, and15, respectively. Projectedmean survival timeswere: 16.7,
13.7, 11.4, and 9.4 years for the sameGFR categories. Themodelwas calibratedwith
mortality data reported by the U.S. Renal Data System. CONCLUSIONS: The model
can project the potential impact of baseline GFR on long-term outcomes in CKD.
Estimating the time spent in GFR categories allows quantification of the entire
trajectory of CKDuntil renal failure or death. In future, themodelmay be refined by
incorporating additional empirical data describing longer-term follow-up.
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OBJECTIVES: To demonstrate if a nationally representative panel dataset can be
used to evaluate if quality of life (QoL) impacts are associated with changes in body
mass index (BMI). The aim was to estimate the utility increments (or decrements)
associated with weight loss (or gain) for application in economic evaluations of
obesity interventions. METHODS: Data from the Household, Income and Labour
Dynamics in Australia survey (HILDA) was used in the analysis. HILDA is a house-
hold-based panelwith 17,209 individuals from6,987 households collected annually
since 2001. This survey uses the SF-36 and the transformed SF-6D utility weight to
capture quality of life. Currently, there are 5 waves providing information on BMI.
The panel nature of the data was exploited with econometric techniques to show
the effect of changes in BMI (between different BMI classification groups) on quality
of life. RESULTS: The results demonstrated that being under-weight, over-weight
or obese is associated with reduced quality of life. When adjusting for other ex-
planatory variables, only the association between the obese category and dimin-
ished quality of life remained. The results from the panel data identified that only
those who remain severely obese over time experience significant reductions in
quality of life. Movements between other BMI categories were not associated with
significant impacts on quality of life. CONCLUSIONS: Economicmodels that assess
the cost-effectiveness of obesity interventions using cross-sectional data may
overestimate the QoL gain following a reduction in BMI. This could lead to non-
optimal policy oriented decisions. Population panel datasets may provide a better
estimate. Using econometric techniques alongside traditional cost-effectiveness
models offers a richer avenue of obtaining model inputs and more certainty in
regards to quantifying gains and losses in QoL.
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OBJECTIVES: Hepatitis B virus (HBV) is estimated to infect 350 million people all
over the world. Most infection with HBV do not induce clinical liver disease, while
less than 30% of them develop severe liver disease. We do not know, however, the
approximate number of the annual newly HBV infection and/or HBV development
in Japan. Then, we make Markov model with HBV infection and estimate annual
probability to disease development.METHODS:We reviewed clinical research pa-
per related to HBV infection published in Japan until December 2011. To research
Japanese original data, we used ‘Igaku Chuo Zasshi’ (Japanese medical journals
database), and JapaneseMinistry of Health, Labour andWelfare research database.
We then extracted some parameters (e.g., patients outcome, treatment, time hori-
zon) and calculated annual probability of disease development. RESULTS: We
made HBV infection model and estimate annual probability to disease develop-
ment from 22 eligible Japanese research papers and reports. The HBV Markov
model started from HBs antigen negative, then HBV infection, divided into 2 col-
umns (asymptomatic career, acute hepatitis) and so on. Each columns annual
probability were detected from clinical trial data in Japan. CONCLUSIONS: We
estimated HBV infection and related diseases progress probability by one-year in
Japan.Wewill estimate the cost of each diseases treatment, patient’s quality of life,
and then we will make Japanese HBV Markov model near future.
RESEARCH ON METHODS - Patient-Reported Outcomes Studies
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OBJECTIVES:A reliable and validmeasure is essential to evaluating and enhancing
patient medication adherence. There is no validated patient-reported medication
adherence measure in Singapore. This study aimed to validate the 8-item Morisky
Medication Adherence Scale (MMAS) in patients taking warfarin in Singapore.
METHODS: A cross-sectional survey was conducted in a convenient sample of 174
patients taking warfarin at an anticoagulation clinic in Singapore in 2011. Socio-
demographics and International Normalized Ratio (INR) valueswere obtained from
patient interview and hospital databases. Respondents completed the MMAS in
English or Chinese depending on their preference. The scale scores ranged from 0
to 8, with higher scores indicating better medication adherence. Reliability was
assessed using Cronbach’s alpha. Criterion-related validity was examined by relat-
ing the MMAS score to warfarin refill rate. Construct validity was examined via
factor analysis and hypothesis testing. RESULTS: The reliability of the MMAS was
moderate (Cronbach’s alpha  0.56). The scale scores were associated with warfa-
rin refill rates (p  0.02). Confirmatory factor analysis showed that the eight items
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loaded onto one factor (RMSEA  0.048). Respondents with higher MMAS scores
had a higher percentage of INRs within the therapeutic range during the past 2
weeks (p  0.02), higher adherence to diet recommendations (p  0.01), and less
perceived difficulty in taking all medications (p 0.01). Respondents with higher
scale scores were also more likely to take warfarin at the same time every day (p
0.001) and follow the prescribed dosage (p  0.04). The hypotheses regarding the
association between the scale score and the timewithin the therapeutic INR range,
however, were not met. CONCLUSIONS: The 8-itemMMAS had a good validity and
moderate reliability in patients taking warfarin. Future research requires investi-
gation of the scale’s reliability and psychometric properties in other patient popu-
lations and clinical settings.
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OBJECTIVES: The EQ-5D-5L questionnaire describes a person’s health using five
5-point Likert scales (i.e. no/slight/moderate/severe/extreme problems), with one
scale for each of its five dimensions including mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression. The purpose of this study was to assess
the equivalence of the response options of the EQ-5D-5L scales across the three
major languages (English, Chinese and Malay) in Singapore.METHODS: Visitors to
9 government-run polyclinics were interviewed face-to-face according to partici-
pants’ language preference. Participants’ perception of the severity of health prob-
lems represented by the response labels of the EQ-5D-5L was measured using a 0
(no problems) to 100 (the worst problems) visual analog scale. The participants
were also asked to use the response labels to describe 25 predefined scenarios of
health states. Severity ratings and choice of labels were analyzed using multiple
linear and logistic regression models, respectively. RESULTS: A total of 743 partic-
ipants (54% ethnic Chinese, 35.3% Malays and 6.6% Indians, age ranged 19 - 83
years) rated the severity of the EQ-5D-5L response labels in English (n257), Chi-
nese (n256) orMalay language versions (n230). Using English labels as reference,
the Chinese response labels perceived were similar in severity of health problems.
Higher severity scores of ‘slight problems’ and lower scores of ‘extreme problems’
however were assigned to Malay response labels. When asked to describe hypo-
thetical health states, users of the Chinese labels tended to usemild wordingwhile
users of the Malay labels tended to use more severe wording. CONCLUSIONS: The
interpretations of the labels for some EQ-5D-5L response options differ between
Malay and other languages in Singapore. Future research is needed to improve the
equivalence of the EQ-5D-5L response options so that the questionnaire can be
used to compare the health status of culturally different populations in Singapore.
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OBJECTIVES: To obtain population norms (using norm based algorithms) of SF36v2
health survey and association of SF36v2 summary component scores with demo-
graphic and socioeconomic variables in Penang general population. This study also
aimed to find out effect size difference between United States and Penang specific
summary scores. METHODS: A cross-sectional study was carried out among 398
residents randomly selected from 10 grids in Penang Island during January 2011
using the official translation of SF-36v2 Health Survey questionnaire in Malay,
Mandarin, Tamil and English. 0-100 scoring of questionnaire was done by scoring
software version 4 for SF-36v2 and then these scores were transformed into norm
based scores by usingmeans and standard deviations derived from Penang general
population. PCS and MCS scores were derived from Penang specific z-scores of
eight health domains and factor coefficients derived fromU.S standard population.
Penang specific scores considered measurement equivalence, if the effect size dif-
ference was 0.5. RESULTS:Mean (SD) norm based scores for PF, RF, BP, GH, VT,
SF, RE and MH were 49.610.6, 50.09.9, 50.09.9, 50.010.0, 50.010.0, 50.09.9,
49.910.1, 50.09.9, respectively. Penang specific PCS and MCS were 49.99.2,
50.09.2, respectively. Physical healthwas determined by age group,marital status
and level of education whereby, Malay ethnicity, un-employment and lower level
of education&monthly incomewas associatedwith poormental health. The effect
size difference betweenU.S standard and Penang specific PCS andMCS scoreswere
0.5. CONCLUSIONS: Since norm based means scores for SF-36v2 health survey
were not available for Malaysian population, therefore these findings can serve as
a baseline for comparisons in future surveys looking at HRQoL in general and
diseased population. The high level of measurement equivalence of the PCS and
MCS between U.S and Penang populations suggests that data pooling between two
populations could be possible.
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OBJECTIVES: The cost of informal care is often ignored in economic evaluation. For
certain conditions, such as palliation or patients with long-term chronic condi-
tions, informal care costs may be substantial. Previous studies have suggested a
limited framework for valuing informal care. The aim of this study was to investi-
gate whether different tasks provided by informal carers are quantified and valued
differently.METHODS: Sixty adults in New SouthWales (Australia) with traumatic
brain injury or spinal cord injury that required long-term 24-hour care were re-
cruited into the study. The amount of care provided to each patient (divided into
tasks, such as: personal care, food preparation, organisational and social support)
was recorded using diary and recall methods. Informal care was valued using
contingent valuation, with carers being asked how much they would be willing to
accept from the Government to provide an extra hour of care. Respondents were
asked to value each task separately. RESULTS: The estimates of informal care
provided differed between recall and diary methods (61 hrs/week versus 29 hrs/
week; p0.01). There were good correlation for some tasks (outdoor journeys) and
large disparities for other tasks (personal care, food preparation and cleaning).
Social support was considerably under reported using the diary method (3 hrs/
week vs. 15 hrs/week; p0.01). In terms of task valuation, personal care ($46/hr)
was valued more highly than household tasks ($29/hr) and social support ($29/hr).
CONCLUSIONS: The method used to estimate the amount of informal care pro-
vided is important. Our findings suggest that informal carers have different valu-
ations for different tasks. Consequently applying a single monetary value for in-
formal care in economic evaluations may not be appropriate, since it does not
accurately reflect the heterogeneity of informal care.
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OBJECTIVES: Drive-Through is a very convenient service in many fast food restau-
rants. Our hospital is newly opened in themiddle 2008. Due to growing numbers of
drug refill visits and limited parking space, pharmacy aims to establish a conve-
nient service for patient to refill their prescriptions. METHODS: We visited many
hospitals of drug refill process. Several meetings were held to design the optimal
system in our institution. We divided the process into two steps; first, make an
appointment, second, pick up medicine. After one month constructing facilities
and training related staffs and pharmacists, the first Drive-Through Pharmacy
Service in Taiwan was grand opened in Taipei Medical University Shuang-Ho Hos-
pital on July 1st 2011.We assess the efficacy of this device by utility rate and patient
satisfaction. RESULTS: After starting the Drive-Through service, the utility rate
raised from 17.7% to 47.4% dramatically. More than 80% of patients were satisfied
with this innovate service. Patients needn’t to park vehicles, and wait in line for
payment and receiving medication. Significant time and cost-savings benefits for
patients by making an appointment of prescription refill via the internet or tele-
phone and by picking up medications in three minutes on that day. Comparing
with traditional method that takes at least forty minutes to complete the whole
process, the new service not only save patient’s time but also the parking fee. From
pharmacist prospective, pharmacists dispense those ordered medication during
midnight. In the day time, usually busier than midnight, we can then create more
time to provide more advanced clinical service. Consequently, both patient and
pharmacist are benefit from our Drive-Through Pharmacy service. CONCLUSIONS:
Our innovate service, Drive-Through Pharmacy, provide patient a much easier,
convenient, and cheaper way to pick up their medication. At the same time, phar-
macist has more time to provide more valuable pharmaceutical service.
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OBJECTIVES: Assessments of adherence to warfarin therapy help improve pa-
tients’ warfarin-taking behavior and reduce mortality. This study aimed to com-
pare three medication adherence measures, i.e., the 8-item Morisky Medication
Adherence Scale (MMAS), the 100-point Visual Analogue Scale (VAS), and phar-
macy refill rates, in patients taking warfarin in Singapore. METHODS: A cross-
sectional survey was conducted in a convenient sample of 174 patients taking
warfarin at an anticoagulation clinic in Singapore in 2011. Respondents completed
the MMAS and the VAS in Chinese or English depending on their preference. Phar-
macy refill rates for warfarin and International Normalized Ratio (INR) values were
retrieved from hospital pharmacy databases. The associations among the three
measures were examined by the Spearman correlation. Their associations with
INR values were examined by the Spearman correlation andMann-Whitney U test.
RESULTS: The mean (SD) of the MMAS, the VAS and pharmacy refill rates were 7.0
(1.1), 91.9 (10.8) and 0.9 (0.1), respectively. Using an 80% refill rate as the cut-off
point, 85.1% of the respondents were adherent to their warfarin therapy. The
MMAS scores were associated with VAS scores and pharmacy refill rates (rs  0.23
and 0.18; p 0.01 and 0.02, respectively). No association was found between the
VAS scores and pharmacy refill rates. The MMAS and pharmacy refill rates were
associated with the percentage of INRs within range in the past 2 weeks (p  0.02
and 0.03, respectively). Moreover, pharmacy refill rates were associated with the
percentage of time within the therapeutic INR range in the past 3 months and 2
weeks (rs  0.21 and 0.16; p  0.01 and 0.05, respectively). CONCLUSIONS:Most of
the patients on warfarin were adherent. Pharmacy refill rate may be a better mea-
sure for assessing adherence towarfarin and shows a stronger correlationwith INR
control than MMAS and VAS.
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